VeriMomБезопасен ли oligopeptide-20 при беременности?
No harmonised CLP classification on reproductive toxicity (ECHA Annex VI), no CIR or SCCS safety assessment flagging reproductive risk, and no peer‑reviewed reports of teratogenic or reproductive effects for oligopeptide‑20. As a synthetic oligopeptide (large, hydrophilic), dermal systemic absorption from cosmetic use is expected to be negligible, so exposure in pregnancy from topical use is essentially negligible (sources: ECHA Annex VI; CosIng; PubChem; PubMed search found no reproductive/toxicology reports).
Pregnancy-safe products containing oligopeptide-20
Related ingredients
Frequently asked questions
- Безопасен ли oligopeptide-20 при беременности?
- No harmonised CLP classification on reproductive toxicity (ECHA Annex VI), no CIR or SCCS safety assessment flagging reproductive risk, and no peer‑reviewed reports of teratogenic or reproductive effects for oligopeptide‑20. As a synthetic oligopeptide (large, hydrophilic), dermal systemic absorption from cosmetic use is expected to be negligible, so exposure in pregnancy from topical use is essentially negligible (sources: ECHA Annex VI; CosIng; PubChem; PubMed search found no reproductive/toxicology reports).
- Безопасен ли oligopeptide-20 при грудном вскармливании?
- No evidence of reproductive or lactation-related hazards in authoritative sources (no harmonised classification, no CIR/SCCS concerns, no peer‑reviewed data indicating transfer into milk). With negligible dermal absorption from topical cosmetic use, systemic exposure (and thus transfer into breastmilk) is expected to be negligible (sources: ECHA Annex VI; CosIng; PubChem; PubMed).
- Безопасен ли oligopeptide-20 для кожи малыша?
- No evidence of developmental/infant toxicity or mechanistic reproductive hazard. However, because infant skin has a less mature barrier and higher surface‑area‑to‑weight, a conservative increase in exposure rating is applied (+1) despite peptide’s generally poor dermal penetration; adult systemic exposure is expected negligible, but infant exposure potential is low but measurable for topical application (sources: general dermal absorption principles, CosIng, PubChem; no infant‑specific studies found in PubMed).
- Как VeriMom оценивает oligopeptide-20?
- VeriMom оценивает oligopeptide-20 в 100/100 (без известных рисков) на основе EU CosIng, классификаций ECHA и исследований PubMed.
- Какие безопасные альтернативы oligopeptide-20 при беременности?
- См. наш список безопасных альтернатив oligopeptide-20 с аналогичной функцией и классификацией без известных рисков.
Проверь любой состав за 2 секунды
Скачай VeriMom бесплатно — отсканируй любой продукт и мгновенно получи оценку безопасности при беременности.
Медицинская оговорка
Данная информация предоставлена исключительно в образовательных целях и не является медицинской рекомендацией. Оценки безопасности основаны на общедоступных данных и могут не отражать все риски. Всегда консультируйтесь с вашим врачом перед использованием любых средств во время беременности или грудного вскармливания.